Carfilzomib (PR-171), 5mg

Carfilzomib (PR-171), 5mg

Carfilzomib (PR-171), 200mg

Carfilzomib (PR-171), 200mg

Carfilzomib (PR-171), 50mg

3.903,20 RON
SKU
SKM_S2853_50mg

Carfilzomib (PR-171) is an irreversible proteasomeinhibitor with IC50of <5 nM in ANBL-6 cells, displayed preferential in vitro inhibitory potency against the ChT-L activity in the β5 subunit, but little or no effect on the PGPH and T-L activities. Carfilzomib activates prosurvival autophagyand induces cell apoptosis.

Mai multe informatii
Price 3.280,00 RON (preturile sunt fara TVA)
Description

Carfilzomib (PR-171) is an irreversible proteasomeinhibitor with IC50of <5 nM in ANBL-6 cells, displayed preferential in vitro inhibitory potency against the ChT-L activity in the β5 subunit, but little or no effect on the PGPH and T-L activities. Carfilzomib activates prosurvival autophagyand induces cell apoptosis.